학술논문
Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis
Document Type
Article
Author
Source
In The Lancet Respiratory Medicine October 2021 9(10):1165-1173
Subject
Language
ISSN
2213-2600